Insulin device market set to increase

As diabetes continues to rise globally, it has been estimated that the insulin delivery devices market value will increase from $8.78 billion in 2012 to $13.8 billion by 2019, at a significant Compound Annual Growth Rate (CAGR) of 7%, says business intelligence provider GBI Research.

The company states that the global prevalence of diabetes will increase by 55% by 2035 to reach 591.1 million. Diabetes prevalence in China and India is forecast to increase to 142.7 million and 109 million by 2035, respectively.

According GBI Research’s latest report - Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers - the growth in the insulin delivery devices market growth in the US and Europe can be put down to an increasing preference for insulin pumps and the uptake of technical advances, such as artificial pancreas devices, in the long term. The growth of diabetes and low penetration of insulin delivery devices in developing countries will also contribute towards the market expansion.

Srikanth Venkataraman, analyst for GBI Research, told Today’s Medical Developments: “Insulin pumps will continue to undergo rapid adoption in North America, where patients are shifting from conventional insulin delivery devices, such as syringes and pens, to insulin pumps. This is due to the need for improved glucose control and flexible, lifestyle-compatible treatment options. The European market will be driven by insulin pen sales thanks to their low cost and ease of use.”

Venkataraman added: “In previous years, fear of injections, coupled with a cultural misconception that the use of injections over oral tablets is a sign of deteriorating health, has impacted negatively on the adoption of insulin delivery devices in Asia-Pacific. However, increasing awareness of the benefits of insulin in managing diabetes will significantly improve the uptake of syringes and pens in this region over the coming years.”